Phosphatidylinositol 4,5-bisphosphate regulates SNARE-dependent membrane fusion

J Cell Biol. 2008 Jul 28;182(2):355-66. doi: 10.1083/jcb.200801056. Epub 2008 Jul 21.

Abstract

Phosphatidylinositol 4,5-bisphosphate (PI 4,5-P(2)) on the plasma membrane is essential for vesicle exocytosis but its role in membrane fusion has not been determined. Here, we quantify the concentration of PI 4,5-P(2) as approximately 6 mol% in the cytoplasmic leaflet of plasma membrane microdomains at sites of docked vesicles. At this concentration of PI 4,5-P(2) soluble NSF attachment protein receptor (SNARE)-dependent liposome fusion is inhibited. Inhibition by PI 4,5-P(2) likely results from its intrinsic positive curvature-promoting properties that inhibit formation of high negative curvature membrane fusion intermediates. Mutation of juxtamembrane basic residues in the plasma membrane SNARE syntaxin-1 increase inhibition by PI 4,5-P(2), suggesting that syntaxin sequesters PI 4,5-P(2) to alleviate inhibition. To define an essential rather than inhibitory role for PI 4,5-P(2), we test a PI 4,5-P(2)-binding priming factor required for vesicle exocytosis. Ca(2+)-dependent activator protein for secretion promotes increased rates of SNARE-dependent fusion that are PI 4,5-P(2) dependent. These results indicate that PI 4,5-P(2) regulates fusion both as a fusion restraint that syntaxin-1 alleviates and as an essential cofactor that recruits protein priming factors to facilitate SNARE-dependent fusion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cell Membrane / ultrastructure
  • Dose-Response Relationship, Drug
  • Exocytosis / drug effects
  • Exocytosis / physiology*
  • Liposomes / metabolism
  • Membrane Fusion / drug effects
  • Membrane Fusion / physiology*
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / metabolism
  • Membrane Microdomains / ultrastructure
  • PC12 Cells
  • Phosphatidylinositol 4,5-Diphosphate / metabolism*
  • Phosphatidylinositol 4,5-Diphosphate / pharmacology
  • Rats
  • SNARE Proteins / metabolism*
  • Syntaxin 1 / drug effects
  • Syntaxin 1 / metabolism
  • Transport Vesicles / drug effects
  • Transport Vesicles / metabolism*
  • Transport Vesicles / ultrastructure

Substances

  • Liposomes
  • Phosphatidylinositol 4,5-Diphosphate
  • SNARE Proteins
  • Syntaxin 1